| Literature DB >> 32047358 |
Jorge Iván Alvarado Sánchez1,2, Juan Daniel Caicedo Ruiz2, Juan José Diaztagle Fernández2,3, Gustavo Adolfo Ospina-Tascón4, Luis Eduardo Cruz Martínez2.
Abstract
INTRODUCTION: Pulse pressure variation (PPV) has been shown to be useful to predict fluid responsiveness in patients ventilated at tidal volume (Vt) >8 mL kg-1. Nevertheless, most conditions in critical care force to use lower Vt. Thus, we sought to evaluate the operative performance of PPV when a Vt ⩽8 mL kg-1 is used during mechanical ventilation support.Entities:
Keywords: Critical care; hemodynamic; perioperative care; pulse pressure; sepsis; tidal volume
Year: 2020 PMID: 32047358 PMCID: PMC6984427 DOI: 10.1177/1179548420901518
Source DB: PubMed Journal: Clin Med Insights Circ Respir Pulm Med ISSN: 1179-5484
Figure 1.Adapted from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009).[20]
Select characteristics of included studies.
| Order | Authors | Year | Setting | Type of study | Sample size | No. of fluid challenge | Method for indices | Infusion volume | Hemodynamic end point | Tidal volume, mL kg−1 | Compliance, mL cm H2O−1) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | De Backer et al.[ | 2005 | Critically ill patients | Prospective cohort | 33 | 33 | PAC | 1000 mL CR or 500 mL HES 10% | Increase in CI ⩾ 15% | 6.3 (6.0-7.1) | 26.0 (23.0-33.0) |
| 2 | Huang et al.[ | 2008 | Critically ill patients | Prospective cohort | 22 | 22 | PAC | 500 mL HES | Increase in CI ⩾ 15% | 6.4 (5.7-1)7. | 26.1 (18.5-33.7) |
| 3 | Auler et al.[ | 2008 | Post cardiac surgery | Prospective cohort | 59 | 59 | PAC | 20 mL kg-1 LR | Increase in CI ⩾ 15% | 8.0 | NR |
| 4 | Vallée et al.[ | 2009 | Critically ill patients | Prospective cohort | 42 | 42 | PiCCO | 6 mL kg−1 HES | Increase in CI ⩾ 15% | 6.0 (6.2-7.3) | 27.0 (23.0-35.0) |
| 5 | Muller et al.[ | 2010 | Critically ill patients | Prospective cohort | 57 | 57 | PAC o PiCCO | 250 or 500 mL saline or HES | Increase in SVI ⩾ 15% | 6.0 (4.8-7.8) IBW | 28.0[ |
| 6 | Lakhal et al.[ | 2011 | Critically ill patients | Prospective cohort? | 65 | 65 | PAC o PiCCO | 500 mL of gelatin | Increase in CO ⩾ 10% | 6.9 (5.95-7.85) PBW | 40.4 (24.6-56.2) |
| 7 | Oliveira-Costa et al.[ | 2012 | Critically ill patients | Cross-sectional observational | 37 | 37 | PAC | 1000 mL saline or LR or 500 mL HES 6% | Increase in CI ⩾ 15% | 6.5 (6.0-6.5) IBW | 34.0 (19.0-49.0) |
| 8 | Monnet et al.[ | 2012 | Critically ill patients | Prospective cohort | 28 | 28 | PiCCO2 | 500 mL saline | Increase in CI ⩾ 15% | 7.1 (6.3-7.9) PBW | 23.0 (20.0-26.0) |
| 9 | Yazigi et al.[ | 2012 | Post cardiac surgery | Prospective cohort | 60 | 60 | PAC | 7 mL kg−1 HES | Increase in SVI ⩾ 15% | 8.0 | NR |
| 10 | Cecconi et al.[ | 2012 | Post high-risk surgery | Prospective cohort | 31 | 47 | LiDCO | 250 mL colloid | Increase in SV ⩾ 15% | 8.0 IBW | NR |
| 11 | Freitas et al.[ | 2013 | Critically ill patients | Prospective cohort | 40 | 40 | PAC | 7 mL kg−1 HES | Increase in CO ⩾ 15% | 6.0 PBW | 31.0 (23.6-37.9) |
| 12 | Trepte et al.[ | 2013 | Intraoperative high-risk surgery | Prospective cohort | 24 | 72 | PiCCO2 | 300 mL HES | Increase in CI ⩾ 10% | 8.0 | NR |
| 13 | Song et al.[ | 2014 | Intraoperative—cardiac surgery | Prospective cohort | 40 | 40 | PAC | 6 mL kg−1 HES | Increase in SVI ⩾ 15% | 8.0 IBW | NR |
| 14 | Ibarra-Estrada et al.[ | 2015 | Critically ill patients | Prospective cohort | 19 | 59 | PiCCO | 7 mL kg−1 saline | Increase in SVI ⩾ 15% | 6.0 (6.0-6.3) PBW | NR |
| 15 | Liu et al.[ | 2016 | Critically ill patients | Prospective cohort | 96 | 96 | PiCCO | 500 mL saline | Increase in CO ⩾ 15% | 7.0 (6.2-7.8) mL kg−1 | 28.0 (15.9-40.1)[ |
| 16 | Myatra et al.[ | 2017 | Critically ill patients | Prospective cohort | 20 | 30 | PiCCO | 7 mL kg-1 saline | Increase in CI ⩾ 15% | 6.0 (5.8-6.2) PWB | 29.0 (21.0-37.0) |
| 17 | Biais et al.[ | 2017 | Intraoperative—neurosurgery | Prospective cohort | 41 | 41 | ProAQT | 250 mL saline | Increase in SVI ⩾ 10% | 6.8 (6.3-7.3) ± IBW | 38.0 (28.0-48.0) |
| 18 | Biais et al.[ | 2017 | Intraoperative—neurosurgery | Prospective cohort | 44 | 88 | ProAQT | 250 mL saline | Increase in SVI ⩾ 10% | 6.9 (6.5-7.2) IBW | 42.2[ |
| 19 | Yonis et al.[ | 2017 | Critically ill patients | Prospective cohort | 19 | 19 | PiCCO | 500 mL LR | Increase in CI ⩾ 15% | 6.0 PBW | 30.0 (23.0-39.0) |
Abbreviations: CI, cardiac index; CO, cardiac output; CR, crystalloid; HES, hydroxyethyl starch; IBW, ideal body weight; LR, Ringer’s lactate; NA, not available; NR: not reported; PAC, pulmonary artery catheter; PBW, predicted body weight; SV, stroke volume; SVI, stroke volume index; PPV, pulse pressure variation.
Values are expressed as pooled value (95% confidence interval) or median (IQR).
Calculated.
Diagnostic performance of pulse pressure variation for prediction of fluid responsiveness in patients with tidal volume ⩽8 mL kg−1 from included studies.
| Order | Authors | Year | tp | n1 | tn | n2 | nt | Sensitivity | Specificity | AUC | Threshold, % | Method use to measure PPV | Fluid responsiveness rate, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | De Backer et al.[ | 2005 | 7 | 18 | 10 | 15 | 33 | 0.39 (0.20-0.61) | 0.65 (0.42-0.85) | 0.71 (0.62-0.80) | PPV ⩾ 12 | Analysis of the monitored arterial tracing | 55.00[ |
| 2 | Huang et al.[ | 2008 | 7 | 10 | 11 | 12 | 22 | 0.70 (0.40-0.89) | 0.92 (0.65-0.99) | 0.76 | PPV ⩾ 11.8 | Analysis of the monitored arterial tracing | 45.45 |
| 3 | Auler et al.[ | 2008 | 38 | 39 | 19 | 20 | 59 | 0.97 (0.87-1.00) | 0.95 (0.76-0.99) | 0.98 (0.97-0.99) | PPV ⩾ 12 | Analysis of the monitored arterial tracing | 66.10 |
| 4 | Vallée et al.[ | 2009 | 6 | 19 | 17 | 23 | 42 | 0.32 (0.15-0.54) | 0.74 (0.54-0.87) | 0.63 (0.45-0.81) | PPV ⩾ 15 | Analysis of the monitored arterial tracing | 46.42[ |
| 5 | Muller et al.[ | 2010 | 25 | 41 | 15 | 16 | 57 | 0.61 (0.46-0.74) | 0.94 (0.72-0.99) | 0.77 (0.65-0.90) | PPV ⩾ 7 | Analysis of the monitored arterial tracing | 72.00 |
| 6 | Lakhal et al.[ | 2011 | 19 | 26 | 33 | 39 | 65 | 0.73 (0.54-0.86) | 0.85 (0.70-0.93) | 0.75 (0.62-0.85) | PPV ⩾ 5 | Analysis of the monitored arterial tracing | 40.00 |
| 7 | Oliveira-Costa et al.[ | 2012 | 9 | 17 | 19 | 20 | 37 | 0.53 (0.31-0.74) | 0.95 (0.76-0.99) | 0.74 (0.56-0.90) | PPV ⩾ 10 | Analysis of the monitored arterial tracing | 44.73 |
| 8 | Monnet et al.[ | 2012 | 14 | 15 | 4 | 13 | 28 | 0.93 (0.79-99)0. | 0.31 (0.13-58)0. | 0.69 (0.68-70)0. | PPV ⩾ 4 | Analysis with PiCCO2 | 53.57 |
| 9 | Yazigi et al.[ | 2012 | 33 | 41 | 14 | 19 | 60 | 0.80 (0.66-0.90) | 0.74 (0.51-0.88) | 0.85 | PPV >11.5 | Analysis of the monitored arterial tracing | 68.33 |
| 10 | Cecconi et al.[ | 2012 | 10 | 12 | 14 | 19 | 31 | 0.83 (0.55-0.95) | 0.74 (0.51-0.88) | 0.87 (0.76-0.99) | PPV >13 | Analysis with LiDCO | 39.00 |
| 11 | Freitas et al.[ | 2013 | 17 | 19 | 19 | 21 | 40 | 0.89 (0.69-0.97) | 0.90 (0.71-0.97) | 0.91 (0.82-1.0) | PPV ⩾ 6.5 | Analysis with computer software | 47.50 |
| 12 | Trepte et al.[ | 2013 | 25 | 41 | 25 | 31 | 72 | 0.61 (0.46-0.74) | 0.81 (0.64-0.91) | 0.70 (0.21-0.85) | PPV ⩾ 10.1 | Analysis with PiCCO2 | 57.00 |
| 13 | Song et al.[ | 2014 | 17 | 23 | 12 | 17 | 40 | 0.74 (0.54-0.87) | 0.71 (0.47-0.87) | 0.74 (0.58-0.90) | PPV ⩾ 13 | Analysis with computer software | 57.50 |
| 14 | Ibarra-Estrada et al.[ | 2015 | 15 | 30 | 23 | 29 | 59 | 0.5 (0.33-0.67) | 0.79 (0.62-0.90) | 0.63 | PPV ⩾ 14 | Analysis of the monitored arterial tracing | 50.80 |
| 15 | Liu et al.[ | 2016 | 35 | 52 | 37 | 44 | 96 | 0.67 (0.54-0.78) | 0.84 (0.71-0.92) | 0.78 (0.69-0.86) | PPV ⩾ 10 | Analysis with PiCCO | 54.16 |
| 16 | Myatra et al.[ | 2017 | 12 | 16 | 13 | 14 | 30 | 0.75 (0.51-90)0. | 0.93 (0.69-99)0. | 0.91 (0.81-0)1. | PPV ⩾ 11.5 | Analysis with computer software | 53.33 |
| 17 | Biais et al.[ | 2017 | 12 | 20 | 18 | 21 | 41 | 0.60 (0.36-0.78) | 0.86 (0.65-0.95) | 0.75 (0.60-0.90) | PPV >9 | Analysis with computer ProAQT | 48.78 |
| 18 | Biais et al.[ | 2017 | 15 | 28 | 41 | 60 | 88 | 0.54 (0.39-0.78 | 0.68 (0.56-0.79) | 0.65 (0.53-0.78) | PPV >10 | Analysis with computer Pulsioflex | 31.81 |
| 19 | Yonis et al.[ | 2017 | 3 | 9 | 8 | 10 | 19 | 0.33 (0.12-0.65) | 0.8 (0.49-0.94) | 0.49 (0.21-0.77) | PPV >10 | Analysis with computer software | 47.36 |
Abbreviations: tn, true negative; tp, true positive; PPV, pulse pressure variation.
Values are expressed as pooled value (95% confidence interval). AUC; area under curve; n1, number of patients who were positive fluid responsiveness; n2, number of patients who were negative fluid responsiveness; nt, number total of patients included.
Calculated.
Figure 2.Sensitivity of pulse pressure variation in patients with tidal volume ⩽8 mL kg−1.
Figure 4.Diagnostic odds ratio of pulse pressure variation in patients with tidal volume ⩽8 mL kg−1.
Figure 5.Summary ROC curve. Solid closed curve: 95% confidence region; dotted closed curve: 95% prediction region; solid line: summary ROC curve; open circle: summary estimate; close circle: study.
Figure 6.Contour enhanced funnel plot for a meta-analysis of pulse pressure variation for prediction of fluid responsiveness in patients with tidal volume ⩽8 mL kg−1. Filled circles show an estimated treatment effect (Log diagnostic odds ratio) and its precision (standard error). In addition to individual study results, the fixed-effect estimates (vertical dashed line) with 95% confidence interval limits (diagonal dashed lines) and the random-effects estimate (vertical dotted line) are shown in the figure.
Figure 7.Funnel plot for meta-analysis analysis of pulse pressure variation for prediction of fluid responsiveness in patients with tidal volume ⩽8 mL kg−1 after applying the trim-and-fill method. Filled circles in the figure show trials included in the meta-analysis, whereas open circles in the figure show unpublished trials.